Global Market Insights on Needle-Free Drug Delivery Systems: Insights and Forecast, 2018-2025: Emphasis on Product (Prefilled needle-free injection systems, Prefilled needle-free injection systems); Technology (Jet Injectors, Transdermal Drug Delivery Systems, Inhaler Technology); Application (Insulin Delivery, Vaccination, Pediatric Injections, Pain Management); Injection Mode (Powder injections, Liquid injections, Liquid injections); Source of Power (Spring Loaded Jet Injector, Gas Powered Jet Injector, Battery Powered Jet Injector) and Region
- UNI3007741
- 122 Pages
- March 2019
- Healthcare
Needle-free drug delivery device provides a solution to deliver drug into the host body without piercing the skin. Major Needle-free technology available in the market includes pens, jet injector, and micro patches among others. The main aim of the technology is to enhance the self-administration of drugs and medications such as insulin in case of diabetic patients. Steady growth in population with chronic diseases paired with sharps injuries associated with the needle act as catalyst that fuels the growth of the needle-free drug delivery device market. The needle-free drug devices are found in disposable and reusable forms, which eliminates the risk of cross-contamination. These devices are suitable and safe for the delivery of drugs to some of the most sensitive parts of the body like cornea and other complicated human body parts. Some of the available needle-free drug delivery devices are Biojector, Jupiter jet, Vitajet-3 and Chemlock, among others.
The market for needle free drug delivery devices is expanding as it has the capability to make the administration of medicines easier, safer and convenient. According to the surveys held in 2017, it was estimated that 91% of the patients were satisfied with the use of needle-free drug delivery technique for drug delivery. Emerging economies are ready to invest capital in this rapidly growing technology. Usage of needleless devices for treatments is causing an impact on society, specifically on those who have suffered from trypanophobia. According to several organizations, 24% of parents and 63% of children suffer from the fear of needles. As a result, 7% of children globally do not get proper vaccinations when required. Needle Free drug delivery devices would serve the purpose by providing quick treatment options at home, through self-administration or injecting the medication when required. The global needle free drug delivery devices market generated revenue of US$ 7.3 billion in 2017 and is expected to be one of the fastest growing markets in the medical industry.
“Prefilled occupy the maximum share in the global market.”
Based on product, the global needle-free drug-device market is segmented into prefilled and fillable needle-free injection system. Prefilled injection system occupies the maximum share in the global market and is expected to remain dominant throughout the forecast period 2018-2025. However, the fillable injection system is expected to witness the highest CAGR growth during the same period.
“Jet Injector is the most popular and leading device among the population.”
The market is further bifurcated on the basis of technology into jet injectors, transdermal drug delivery systems and inhaler technology. Jet Injector is the most popular and leading device among the population as it involves zero contamination and individual can use the product without medical professionals.
“Liquid injection dominates the market and is anticipated to show a remarkable growth.”
Based on the injection method, global needle-free drug-device is classified into powder injections, liquid injections, and depot or projectile injection. These systems are designed to inject drug into skin, tissues, and muscles using solid and liquid dosages accordingly. The liquid injection holds the largest share and is anticipated to show a remarkable CAGR during the forecast period.
“Insulin Delivery occupies the lead share among other applications.”
The global needle-free drug-device industry is further segmented based on different applications such as Insulin delivery, vaccinations, pediatric injections and pain management. Majority of the population use this device for insulin delivery as the prevalence of diabetes is increasing in both developed and developing countries on a brisk pace.
“Amongst the Source of Power, the gas-powered jet injector leads share in the global market.”
The market is also bifurcated on the basis of source of power into spring load jet Injector systems, gas powdered jet injector and battery powdered jet injector system. Among these, the gas-powered jet injector dominated the market and is expected to maintain its consistency by 2025. However, the battery-powered jet injector system is expected to grow at a noticeable CAGR during the forecast period.
“North America holds the prominent share in Global Needle-Free Drug-Device Market.”
For a deep dive analysis of the industry, global needle-free drug-device market is analyzed based on geographies and regions such as North America, Europe, Asia-Pacific and rest of the world. North America constituted the highest market share of needle-free drug delivery device industry. However, Asia Pacific region is expected to be the leading market in the near future.
Competitive Landscape-Top 10 Market Players
Some of the major players operating in the global needle free durg delivery device market are Antares Pharma, Consort Medical, Crossject, Inovio Pharmaceuticals, Injex Pharma, Medical International Technology, Valeritas, Zasona, 3M, and Pharmajet. Being a new technology, majority of the companies operating in the industry are spending money on R&D to come up with innovative devices in the domain to cater to the increasing demand majorly from the developing region along with region with most prominent elderly population.
Reasons to buy:
• The needle free drug delivery device market study presents the current market size, trend, forecast until 2024. The analysis presented in the report is a combination of deep dive secondary research and input from Key Opinion Leader of the industry
• The report presents a quick review of overall industry performance at one glance
• The report covers in depth analysis of prominent industry peers with primary focus on key business financials, product portfolio, expansion strategies and recent developments
• Detailed examination on drivers, restraints, key trends and opportunities prevailing in the industry.
• Examination of industry attractiveness with the help of Porter’s Five Forces analysis
• The study comprehensively covers the market across different segments and sub segments
• Deep dive regional level analysis of the industry
Customization Options:
The Needle Free Drug Delivery Device Market can be customized to country level or any other market segment. Besides this, UMI understands that you may have your own business need, hence we also provide fully customized solutions to clients.
1.1 Market Definition 12
1.2 Objective of the Study 12
1.3 Limitation 12
1.4 Stakeholders 13
1.5 Currency used in the Report 13
2. RESEARCH METHODOLOGY OR ASSUMPTION 14
2.1 Research Methodology for Global Needle Free Drug Delivery Devices Market 14
2.1.1 Main objective of the Needle Free Drug Delivery Devices Market Study 15
3. REGULATORY FRAMEWORK AND KEY DEVELOPMENT 16
3.1 General Overview 16
3.1.1 North America 16
3.1.2 Europe 17
4. INDUSTRY PERFORMANCE 18
5. EXECUTIVE SUMMARY 20
6. MARKET OVERVIEW 23
6.1 Introduction 23
6.2 Market Dynamics 24
6.2.1 Market Trend & Drivers 24
6.2.2 Rising Prevalence of Chronic and Lifestyle Diseases 24
6.2.3 Inclination Towards Self Administration of Drugs 26
6.2.4 Growing Technological Advancements in the Devices 27
6.3 Market Challenges 27
6.3.1 Ambiguity in the Specifications of Needle Free Devices 27
6.3.2 Limitations associated with Micro Needle Patches 28
6.4 Market Opportunities 28
6.4.1 Increase in the number of start-ups and Investments 28
6.4.2 Growing Adoption in Emerging Countries of Asia-Pacific Region 30
7. KEY MARKET INDICATORS 31
7.1 General Overview 31
7.1.1 Demand and Supply Side Analysis 31
7.1.1.1 Top Winning Strategies 32
7.1.1.1.1 Top Product launches 32
7.1.1.1.2 Top Business Expansions & Investments 33
7.1.1.1.3 Top Acquisition and Collaborations 34
7.1.2 Needle-free injection technology manufacturing process value chain 35
8. MARKET INSIGHTS BY PRODUCT TYPE (2018-25) 37
8.1 General Overview 37
8.1.1 Prefilled needle-free injection systems 38
8.1.2 Fillable needle-free injection systems 39
9. MARKET INSIGHTS BY TECHNOLOGY (2018-25) 41
9.1 General Overview 41
9.1.1 Jet Injectors 42
9.1.2 Transdermal Drug Delivery Systems 43
9.1.3 Inhaler Technology 44
10. MARKET INSIGHTS BY APPLICATION TYPE (2018- 2025) 46
10.1 General Overview 46
10.1.1 Insulin Delivery 47
10.1.2 Vaccination 48
10.1.3 Pediatric Injections 49
10.1.4 Pain Management 50
11. MARKET INSIGHTS BY INJECTION METHODS 51
11.1 General Overview 51
11.1.1 Powder injections 52
11.1.2 Liquid injections 53
11.1.3 Depot or Projectile Injection 54
12. MARKET INSIGHTS BY SOURCE POWER 55
12.1 General Overview 55
12.1.1 Spring Loaded Jet Injector 56
12.1.2 Gas Powered Jet Injector 57
12.1.3 Battery Powered Jet Injector 58
13. MARKET INSIGHTS BY REGION 59
13.1 General Overview 59
13.1.1 North America Needle-Free Drug Delivery Market (2018-2025) 60
13.1.1.1 North America Needle Free Drug Delivery Market, by Product 62
13.1.1.2 North America Needle-Free Drug Delivery Market, by Technology 62
13.1.1.3 North America Needle-Free Drug Delivery Device Market, by Application 63
13.1.1.4 North America Needle-Free Drug Delivery Market, by Injection Method 63
13.1.1.5 North America Needle Free Drug Delivery Device Market by, Source of Power 64
13.1.2 Europe Needle-Free Drug Delivery Device Market (2018-2025) 64
13.1.2.1 Europe Needle-Free Drug Delivery Device Market, by Product 68
13.1.2.2 Europe Needle-Free Drug Delivery Device Market, by Technology 68
13.1.2.3 Europe Needle-Free Drug Delivery Device Market, by Application 69
13.1.2.4 Europe Needle Free Drug Delivery Device Market, by Injection Method 69
13.1.2.5 Europe Needle-Free Drug Delivery Device Market, by Source of Power 70
13.1.3 Asia Pacific Needle-Free Drug Delivery Device Market (2018-2025) 70
13.1.3.1 Asia Pacific Needle-Free Drug Delivery Device Market, by Product 74
13.1.3.2 Asia Pacific Needle-Free Drug Delivery Device Market, by Technology 74
13.1.3.3 Asia Pacific Needle Free Drug Delivery Device Market, by Application 75
13.1.3.4 Asia Pacific Needle-Free Drug Delivery Device Market, by Injection Method 75
13.1.3.5 Asia Pacific Needle-Free Drug Delivery Device Market, by Source of Power 76
13.1.4 Rest of World Needle-Free Drug Delivery Device Market (2018-2025) 76
13.1.4.1 RoW Needle-Free Drug Delivery Device Market, by Product 78
13.1.4.2 RoW Needle-Free Drug Delivery Device Market, by Technology 78
13.1.4.3 RoW Needle-Free Drug Delivery Device Market, by Application 79
13.1.4.4 RoW Needle Free Needle-Free Device Market, by Injection Method 79
13.1.4.5 RoW Needle-Free Drug Delivery Device Market by Source of Power 80
14. COMPETITIVE SCENARIO 81
14.1 Porter’s Five forces analysis 81
14.1.1 Bargaining power of Buyer 81
14.1.2 Bargaining power of Supplier 82
14.1.3 The threat of new entrants 82
14.1.4 Availability of Substitute 83
14.1.5 Industry Rivalry 83
14.2 Global Needle-Free Drug Delivery Market Share Analysis, 2017 84
15. COMPANY PROFILES 85
15.1 Antares Pharma, Inc. 85
15.1.1 Key Facts 85
15.1.2 Business Description 85
15.1.3 Key Product/Services Offerings 86
15.1.4 SWOT Analysis 87
15.1.5 Key Financials 87
15.1.6 Revenue Split 88
15.1.7 Recent Developments 88
15.1.8 Funding 89
15.2 Consort Medical 90
15.2.1 Key Facts 90
15.2.2 Business Description 90
15.2.3 Key Product/Services Offerings 91
15.2.4 SWOT Analysis 92
15.2.5 Key Financials 92
15.2.6 Revenue Split 93
15.2.7 Recent Developments 93
15.3 Crossject Société Anonyme 94
15.3.1 Key Facts 94
15.3.2 Business Description 94
15.3.3 SWOT Analysis 95
15.3.4 Key Financials 95
15.3.5 Revenue Split 96
15.3.6 Recent Developments 96
15.3.7 Funding 96
15.4 Inovio Pharmaceuticals 97
15.4.1 Key Facts 97
15.4.2 Business Description 97
15.4.3 SWOT Analysis 99
15.4.4 Key Financials 100
15.4.5 Revenue Split 100
15.4.6 Recent Developments 101
15.4.7 Funding 101
15.5 Injex Pharma 102
15.5.1 Key Facts 102
15.5.2 Business Description 102
15.5.3 Key Product/Services Offerings 102
15.5.4 SWOT Analysis 103
15.6 Medical International Technology 104
15.6.1 Key Facts 104
15.6.2 Business Description 104
15.6.3 Key Product/Services Offerings 105
15.6.4 SWOT Analysis 105
15.6.5 Key Financials 106
15.6.6 Revenue Split 106
15.6.7 Recent Developments 106
15.7 Zosano Pharma 107
15.7.1 Key Facts 107
15.7.2 Business Description 107
15.7.3 Key Product/Services Offerings 108
15.7.4 SWOT Analysis 108
15.7.5 Key Financials 109
15.7.6 Revenue Split 109
15.7.7 Recent Developments 110
15.8 Valeritas 111
15.8.1 Key Facts 111
15.8.2 Business Description 111
15.8.3 Key Product/Services Offerings 112
15.8.4 SWOT Analysis 112
15.8.5 Recent Developments 113
15.8.6 Funding 113
15.9 3M 114
15.9.1 Key Facts 114
15.9.2 Business Description 114
15.9.3 Key Product/Services Offerings 115
15.9.4 SWOT Analysis 116
15.9.5 Key Financials 116
15.9.6 Revenue Split 117
15.9.7 Recent Developments 117
15.9.8 Funding 117
15.10 PharmaJet 118
15.10.1 Key Facts 118
15.10.2 Business Description 118
15.10.3 Key Product/Services Offerings 118
15.10.4 SWOT Analysis 119
15.10.5 Recent Developments 120
15.10.6 Funding 120
TABLE 2 Examples of Prefilled Needle Free Devices 27
TABLE 3 Examples of Prefilled Needle-Free Devices 38
TABLE 4 Global Prefilled Needle-Free Injection System by Region, 2018-25 (US$ Billion) 39
TABLE 5 Global Fillable Needle Free Injection System by Region, 2018-25 (US$ Billion) 39
TABLE 6 Global Jet Injector Market Size by Region, 2018-25 (US$ Billion) 42
TABLE 7 Global Transdermal Drug Delivery Systems, by Region, 2018-25 (US$ Billion) 43
TABLE 8 Global Inhaler Technology by Region, 2018-25 (US$ Billion) 44
TABLE 9 Global Needle-Free Insulin Delivery Market by Region, 2018-25 (US$ Billion) 47
TABLE 10 Global Needle-Free Vaccination Market by Region, 2018-25 (US$ Billion) 48
TABLE 11 Global Needle-Free Paediatric Injection Market by Region, 2018-25 (US$ Billion) 49
TABLE 12 Global Needle-Free Pain Management Market, by Region, 2018-25 (US$ Billion) 50
TABLE 13 Specification of Needle-Free Devices By Injection Methods 52
TABLE 14 Global Needle-Free Powdered Injection Market by Region, 2018-25 (US$ Billion) 53
TABLE 15 Examples of Drugs Administered via Liquid Jet Injector 53
TABLE 16 Global Needle-Free Liquid Injection Market by Region, 2018-25 (US$ Billion) 54
TABLE 17 Global Needle-Free Depot or Projectile Injection Market by Region, 2018-25 (US$ Billion) 54
TABLE 18 Global Needle-Free Spring Loaded Jet Injector Market by Region, 2018-25 (US$ Billion) 56
TABLE 19 Global Needle-Free Gas Powered Jet Injector Market by Region, 2018-25 (US$ Billion) 57
TABLE 20 Global Needle-Free Battery Powered Jet Injector Market by Region, 2018-25 (US$ Billion) 58
TABLE 21 North America Needle Free Drug Delivery Device by Product 2018-25 (US$ Billion) 62
TABLE 22 North America Needle-Free Drug Delivery Device by Technology, 2018-25 (US$ Billion) 62
TABLE 23 North America Needle-Free Drug Delivery Device by Application,2018-2025 (US$ Billion) 63
TABLE 24 North America Needle-Free Drug Delivery Device by Injection Method, 2018-25 (US$ Billion) 63
TABLE 25 North America Needle-Free Drug Delivery Device, by Source of Power, 2018-25 (US$ Billion) 64
TABLE 26 Europe Needle-Free Drug Delivery Device by Product, 2018-25 (US$ Billion) 68
TABLE 27 Europe Needle-Free Drug Delivery Device by Technology, 2018-25 (US$ Billion) 68
TABLE 28 Europe Needle-Free Drug Delivery Device by Application,2018-2025 (US$ Billion) 69
TABLE 29 Europe Needle-Free Drug Delivery Device by Injection Method, 2018-25 (US$ Billion) 69
TABLE 30 Europe Needle-Free Drug Delivery Device, by Source of Power, 2018-25 (US$ Billion) 70
TABLE 31 Mortality from CVD, Cancer, Diabetes or CRD between 30 and 70 Years (%) in Asia-Pacific 71
TABLE 32 Asia Pacific Needle-Free Drug Delivery Device by Product, 2018-25 (US$ Billion) 74
TABLE 33 Asia Pacific Needle-Free Drug Delivery Device by Technology, 2018-25 (US$ Billion) 74
TABLE 34 Asia Pacific Needle-Free Drug Delivery Device by Application, 2018-2025 (US$ Billion) 75
TABLE 35 Asia Pacific Needle-Free Drug Delivery Device by Injection Method, 2018-25 (US$ Billion) 75
TABLE 36 Asia Pacific Needle-Free Drug Delivery Device by Source of Power, 2018-25 (US$ Billion) 76
TABLE 37 Mortality from CVD, Cancer, Diabetes or CRD between 30 and 70 Years (%) in RoW 77
TABLE 38 RoW Needle-Free Drug Delivery Device Market by Product, 2018-25 (US$ Billion) 78
TABLE 39 RoW Needle-Free Drug Delivery Device Market by Technology, 2018-25 (US$ Billion) 78
TABLE 40 RoW Needle-Free Drug Delivery Device Market by Application,2018-2025 (US$ Billion) 79
TABLE 41 RoW Needle-Free Drug Delivery Device Market by Injection Method, 2018-25 (US$ Billion) 79
TABLE 42 RoW Needle-Free Drug Delivery Device Market by Source of Power, 2018-25 (US$ Billion) 80
TABLE 43 Antares Pharma Inc. Key Facts 85
TABLE 44 Product segmentation of Antares Pharma Inc. 86
TABLE 45 Antares Pharma, Inc. Growth Strategy 86
TABLE 46 Antares Pharma Inc. Financials US $ Million 87
TABLE 47 Consort Medical Key Facts 90
TABLE 48 Product segmentation of Consort Medical 91
TABLE 49 Consort Medical Growth Strategy 91
TABLE 50 Consort Medical Financials, US$ Million 92
TABLE 51 Crossject Société Key Facts 94
TABLE 52 Product segmentation of Crossject Société Anonyme 94
TABLE 53 Crossject Société Anonyme Growth Strategy 95
TABLE 54 Crossject Société Anonyme Financials, US$ Million 95
TABLE 55 Inovio Pharmaceutical Key Facts 97
TABLE 56 Product segmentation of Inovio Pharmaceuticals 98
TABLE 57 Inovio Pharmaceuticals Growth Strategy 99
TABLE 58 Inovio Pharmaceuticals Financials, US$ Million 100
TABLE 59 Injex Pharma Key Facts 102
TABLE 60 Product segmentation of Injex Pharma 102
TABLE 61 Injex Pharma Growth Strategy 103
TABLE 62 Medical International Technology Key Facts 104
TABLE 63 Product segmentation of Medical International Technology 105
TABLE 64 Medical International Technology Growth Strategy 105
TABLE 65 Medical International Technology Financials, US$ Million 106
TABLE 66 Zosano Pharma Key Facts 107
TABLE 67 Product segmentation of Zosano Pharma 108
TABLE 68 Zosano Pharma Growth Strategy 108
TABLE 69 Zosano Pharma Financials, US$ Million 109
TABLE 70 Valeritas Key Facts 111
TABLE 71 Product segmentation of Valeritas 112
TABLE 72 Valeritas Growth Strategy 112
TABLE 73 3M Key Facts 114
TABLE 74 Product segmentation of 3M 115
TABLE 75 3M Growth Strategy 115
TABLE 76 3M Financials, US$ Million 116
TABLE 77 PharmaJet Key Facts 118
TABLE 78 Product segmentation of PharmaJet 118
TABLE 79 Pharmajet Growth Strategy 11
Similar Reports
The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...
- Publish Date: February 26, 2018
- $5370
The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...
- Publish Date: May 29, 2018
- $5370
The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...
- Publish Date: May 1, 2016
- $5370
